account_num,net_change,tag,tag_depth,cik
2091,4100000.0,AssetsNoncurrent,2,719135_APYX MEDICAL CORP
2347,-1905000.0,AccountsPayableAndAccruedLiabilitiesCurrent,3,719135_APYX MEDICAL CORP
2398,-1905000.0,AccountsPayableCurrent,2,719135_APYX MEDICAL CORP
2089,56784000.0,Assets,1,719135_APYX MEDICAL CORP
2041,1239000.0,OtherAssetsNoncurrent,2,719135_APYX MEDICAL CORP
1368,2109000.0,PropertyPlantAndEquipmentNet,4,719135_APYX MEDICAL CORP
1634,646000.0,OperatingLeaseRightOfUseAsset,2,719135_APYX MEDICAL CORP
868,52684000.0,AssetsCurrent,2,719135_APYX MEDICAL CORP
260,10946000.0,InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings,4,719135_APYX MEDICAL CORP
455,10946000.0,InventoryNet,2,719135_APYX MEDICAL CORP
320,18135000.0,ReceivablesNetCurrent,3,719135_APYX MEDICAL CORP
207,9966000.0,AccountsNotesAndLoansReceivableNetCurrent,4,719135_APYX MEDICAL CORP
229,9966000.0,AccountsReceivableNetCurrent,3,719135_APYX MEDICAL CORP
577,16255000.0,CashCashEquivalentsAndShortTermInvestments,4,719135_APYX MEDICAL CORP
645,16255000.0,CashAndCashEquivalentsAtCarryingValue,3,719135_APYX MEDICAL CORP
2809,-33000.0,FinanceLeaseLiabilityCurrent,3,719135_APYX MEDICAL CORP
2737,-8811000.0,LongTermDebtAndCapitalLeaseObligationsCurrent,3,719135_APYX MEDICAL CORP
3154,-18526000.0,LiabilitiesCurrent,2,719135_APYX MEDICAL CORP
1749,5068000.0,SalariesWagesAndOfficersCompensation,4,719135_APYX MEDICAL CORP
1056,5068000.0,SalariesAndWages,5,719135_APYX MEDICAL CORP
664,4569000.0,AssetsHeldForSaleNotPartOfDisposalGroupCurrent,3,719135_APYX MEDICAL CORP
1515,-5000.0,OtherOperatingIncomeExpenseNet,2,719135_APYX MEDICAL CORP
1895,1740000.0,ProfessionalFees,1,719135_APYX MEDICAL CORP
693,-51000.0,InterestIncomeOperating,2,719135_APYX MEDICAL CORP
3279,-1343000.0,DeferredRevenueNoncurrent,2,719135_APYX MEDICAL CORP
3339,-1343000.0,ContractWithCustomerLiabilityNoncurrent,3,719135_APYX MEDICAL CORP
421,-51000.0,NetInvestmentIncome,1,719135_APYX MEDICAL CORP
2638,-8811000.0,DebtCurrent,2,719135_APYX MEDICAL CORP
1572,106000.0,FinanceLeaseRightOfUseAsset,3,719135_APYX MEDICAL CORP
2431,49000.0,NetIncomeLossAttributableToNoncontrollingInterest,1,719135_APYX MEDICAL CORP
850,-3387000.0,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,7,719135_APYX MEDICAL CORP
1264,-5611000.0,OperatingIncomeLoss,1,719135_APYX MEDICAL CORP
1112,13184000.0,OperatingExpenses,1,719135_APYX MEDICAL CORP
692,142000.0,ProvisionForDoubtfulAccounts,2,719135_APYX MEDICAL CORP
601,5255000.0,SellingGeneralAndAdministrativeExpense,3,719135_APYX MEDICAL CORP
597,6808000.0,GeneralAndAdministrativeExpense,2,719135_APYX MEDICAL CORP
232,-7573000.0,GrossProfit,1,719135_APYX MEDICAL CORP
173,-51000.0,Revenues,1,719135_APYX MEDICAL CORP
3917,-56784000.0,LiabilitiesAndStockholdersEquity,2,719135_APYX MEDICAL CORP
3260,-36214000.0,StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest,2,719135_APYX MEDICAL CORP
3316,-36052000.0,StockholdersEquity,1,719135_APYX MEDICAL CORP
3750,-75235000.0,AdditionalPaidInCapital,1,719135_APYX MEDICAL CORP
3661,-35000.0,CommonStockValue,3,719135_APYX MEDICAL CORP
3465,-20570000.0,Liabilities,1,719135_APYX MEDICAL CORP
3645,-2044000.0,LiabilitiesNoncurrent,2,719135_APYX MEDICAL CORP
3796,-1976000.0,LiabilitiesOtherThanLongtermDebtNoncurrent,3,719135_APYX MEDICAL CORP
3379,-448000.0,OperatingLeaseLiabilityNoncurrent,3,719135_APYX MEDICAL CORP
3303,-68000.0,LongTermDebtAndCapitalLeaseObligations,2,719135_APYX MEDICAL CORP
3853,-162000.0,MinorityInterest,1,719135_APYX MEDICAL CORP
3378,-68000.0,FinanceLeaseLiabilityNoncurrent,3,719135_APYX MEDICAL CORP
2130,-188000.0,NonoperatingIncomeExpense,1,719135_APYX MEDICAL CORP
1709,234000.0,InterestExpense,1,719135_APYX MEDICAL CORP
3834,-39218000.0,RetainedEarningsAccumulatedDeficit,1,719135_APYX MEDICAL CORP
2149,-6033000.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments,3,719135_APYX MEDICAL CORP
2603,-12142000.0,NoninterestIncome,1,719135_APYX MEDICAL CORP
1854,234000.0,InterestAndDebtExpense,2,719135_APYX MEDICAL CORP
110,-12142000.0,RevenueFromContractWithCustomerExcludingAssessedTax,2,719135_APYX MEDICAL CORP
2004,-188000.0,OtherNonoperatingIncomeExpense,1,719135_APYX MEDICAL CORP
581,1121000.0,OperatingCostsAndExpenses,2,719135_APYX MEDICAL CORP
144,4569000.0,CostOfRevenue,1,719135_APYX MEDICAL CORP
171,4569000.0,CostOfGoodsAndServicesSold,2,719135_APYX MEDICAL CORP
3494,-185000.0,OtherLiabilitiesNoncurrent,2,719135_APYX MEDICAL CORP
644,7752000.0,NontradeReceivablesCurrent,2,719135_APYX MEDICAL CORP
491,1121000.0,ResearchAndDevelopmentExpense,2,719135_APYX MEDICAL CORP
2716,-8778000.0,LongTermDebtCurrent,2,719135_APYX MEDICAL CORP
2257,-5799000.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,2,719135_APYX MEDICAL CORP
2399,2267000.0,IncomeTaxExpenseBenefit,1,719135_APYX MEDICAL CORP
599,7752000.0,IncomeTaxesReceivable,2,719135_APYX MEDICAL CORP
1820,-8066000.0,IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest,3,719135_APYX MEDICAL CORP
1077,-3532000.0,ProfitLoss,2,719135_APYX MEDICAL CORP
487,417000.0,OtherReceivablesNetCurrent,3,719135_APYX MEDICAL CORP
1912,-3483000.0,NetIncomeLoss,1,719135_APYX MEDICAL CORP
2590,-3483000.0,NetIncomeLossAvailableToCommonStockholdersBasic,2,719135_APYX MEDICAL CORP
2903,-3483000.0,NetIncomeLossAvailableToCommonStockholdersDiluted,2,719135_APYX MEDICAL CORP
